Alexander Roediger
Alexander Roediger publishes mostly in Economics and Econometrics, General Health Professions and Oncology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer and Pharmaceutical Economics and Policy.
- World rank
- #1,323,240 of 7,710,434 ranked researchers
- Rank in United States
- #420,152 of 1,627,098
- Works
- 35
- Citations
- 484
- Citations per work
- 13.8
What does Alexander Roediger research?
Alexander Roediger's work is mostly in Economics, Econometrics and Finance (58%), Medicine (13%), Health Professions (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences2058.2%
- Health Sciences823.5%
- Medicine513.3%
- Health Professions410.2%
- Everything else618.3%
- 1Economics and Econometrics55% of their works
- 2General Health Professions10% of their works
- 3Oncology7% of their works
- 4Finance3% of their works
- 5Surgery3% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
Which keywords describe Alexander Roediger's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Cost of Care, Financial Toxicity, Drug Development Costs, Generic Drugs, Cancer Incidence and Mortality Rates.
- Universal Coverage
- Private R&D
- Immune Checkpoint Blockade
- Health Care Expenditure
- Mortality Rates
- Generic Drugs
- Financial Toxicity
- Quality of Life
- Cost-effectiveness Analysis
- Cost of Care
- Drug Development Costs
- Cancer Incidence
- Ageing Population
- Health Financing
- PD-1 and PD-L1
- R&D Subsidies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cost-effectiveness Analysis231 topic
- Quality of Life231 topic
- Cost of Care161 topic
- Financial Toxicity161 topic
- Drug Development Costs111 topic
- Generic Drugs111 topic
- Cancer Incidence41 topic
- Mortality Rates41 topic
- Ageing Population31 topic
- Health Care Expenditure31 topic
- Health Financing31 topic
- Immune Checkpoint Blockade31 topic
- PD-1 and PD-L131 topic
- Private R&D31 topic
- R&D Subsidies31 topic
- Universal Coverage31 topic
Where does Alexander Roediger work?
Alexander Roediger's main affiliation in the publication record is Merck & Co., Inc., Rahway, NJ, USA (United States), United States.
How many publications and citations does Alexander Roediger have?
OpenAlex counts 35 works and 484 citations for Alexander Roediger, an h-index of 10, ranking #1,323,240 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alexander Roediger. Posts are plain text and can be reported.